Cannbiorx Life Sciences Stock Working Capital

ATNFW Stock

USD 0.01 0 12.00%

CannBioRx Life Sciences fundamentals help investors to digest information that contributes to CannBioRx Life's financial success or failures. It also enables traders to predict the movement of CannBioRx Stock. The fundamental analysis module provides a way to measure CannBioRx Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CannBioRx Life stock.

	Last Reported	Projected for Next Year
Net Working Capital	-1.4 M	-1.5 M
Change In Working Capital	-14.1 K	-13.4 K

Net Working Capital is likely to drop to about (1.5 M) in 2024. Change In Working Capital is likely to climb to about (13.4 K) in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CannBioRx Life Sciences Company Working Capital Analysis

CannBioRx Life's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current CannBioRx Life Working Capital

(1.42 M)

Most of CannBioRx Life's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CannBioRx Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CannBioRx Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for CannBioRx Life is extremely important. It helps to project a fair market value of CannBioRx Stock properly, considering its historical fundamentals such as Working Capital. Since CannBioRx Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CannBioRx Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CannBioRx Life's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Capital Surpluse	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Debt	Short Term Investments	Accounts Payable	Net Receivables	Good Will	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Intangible Assets	Long Term Debt	Current Deferred Revenue
Total Assets		0.43	0.09	0.69	0.44	0.13	0.88	0.85	0.03	-0.08	0.1	0.22	0.24	0.22	0.13	0.34	-0.25	0.24	0.13	0.23
Total Stockholder Equity	0.43		-0.24	0.53	0.91	0.55	0.63	-0.1	-0.05	-0.64	0.03	0.66	0.18	0.14	-0.08	0.62	-0.28	0.23	-0.07	0.16
Retained Earnings	0.09	-0.24		-0.63	-0.42	-0.72	-0.18	0.29	0.39	0.89	0.45	-0.42	0.89	0.92	0.92	0.39	-0.66	0.84	0.95	0.89
Capital Surpluse	0.69	0.53	-0.63		0.65	0.56	0.83	0.42	-0.15	-0.71	-0.17	0.43	-0.44	-0.48	-0.52	-0.04	0.25	-0.41	-0.53	-0.44
Total Liab	0.44	0.91	-0.42	0.65		0.69	0.65	-0.08	-0.16	-0.74	0.11	0.85	0.0	-0.09	-0.24	0.59	-0.26	0.02	-0.26	-0.02
Total Current Assets	0.13	0.55	-0.72	0.56	0.69		0.22	-0.22	-0.77	-0.76	-0.52	0.78	-0.47	-0.45	-0.76	0.22	0.4	-0.3	-0.74	-0.5
Short Term Debt	0.88	0.63	-0.18	0.83	0.65	0.22		0.59	0.22	-0.43	0.25	0.38	0.04	-0.02	0.02	0.24	-0.23	0.03	-0.01	0.04
Common Stock	0.85	-0.1	0.29	0.42	-0.08	-0.22	0.59		0.08	0.32	0.07	-0.2	0.19	0.21	0.23	0.01	-0.11	0.18	0.23	0.2
Net Debt	0.03	-0.05	0.39	-0.15	-0.16	-0.77	0.22	0.08		0.22	0.73	-0.43	0.36	0.26	0.65	-0.1	-0.54	0.15	0.6	0.4
Short Term Investments	-0.08	-0.64	0.89	-0.71	-0.74	-0.76	-0.43	0.32	0.22		0.23	-0.62	0.61	0.66	0.71	0.05	-0.34	0.56	0.73	0.61
Accounts Payable	0.1	0.03	0.45	-0.17	0.11	-0.52	0.25	0.07	0.73	0.23		0.1	0.47	0.36	0.71	0.24	-0.76	0.39	0.67	0.47
Net Receivables	0.22	0.66	-0.42	0.43	0.85	0.78	0.38	-0.2	-0.43	-0.62	0.1		-0.11	-0.16	-0.3	0.51	-0.12	0.04	-0.31	-0.15
Good Will	0.24	0.18	0.89	-0.44	0.0	-0.47	0.04	0.19	0.36	0.61	0.47	-0.11		0.98	0.88	0.73	-0.86	0.9	0.9	1.0
Net Invested Capital	0.22	0.14	0.92	-0.48	-0.09	-0.45	-0.02	0.21	0.26	0.66	0.36	-0.16	0.98		0.85	0.67	-0.74	0.95	0.89	0.96
Short Long Term Debt	0.13	-0.08	0.92	-0.52	-0.24	-0.76	0.02	0.23	0.65	0.71	0.71	-0.3	0.88	0.85		0.4	-0.81	0.78	0.98	0.88
Capital Stock	0.34	0.62	0.39	-0.04	0.59	0.22	0.24	0.01	-0.1	0.05	0.24	0.51	0.73	0.67	0.4		-0.74	0.69	0.41	0.72
Net Working Capital	-0.25	-0.28	-0.66	0.25	-0.26	0.4	-0.23	-0.11	-0.54	-0.34	-0.76	-0.12	-0.86	-0.74	-0.81	-0.74		-0.68	-0.78	-0.87
Intangible Assets	0.24	0.23	0.84	-0.41	0.02	-0.3	0.03	0.18	0.15	0.56	0.39	0.04	0.9	0.95	0.78	0.69	-0.68		0.84	0.87
Long Term Debt	0.13	-0.07	0.95	-0.53	-0.26	-0.74	-0.01	0.23	0.6	0.73	0.67	-0.31	0.9	0.89	0.98	0.41	-0.78	0.84		0.89
Current Deferred Revenue	0.23	0.16	0.89	-0.44	-0.02	-0.5	0.04	0.2	0.4	0.61	0.47	-0.15	1.0	0.96	0.88	0.72	-0.87	0.87	0.89

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict CannBioRx Life

Working Capital Over Time

CannBioRx Capital Surpluse

Capital Surpluse

3.48 Million

At this time, CannBioRx Life's Capital Surpluse is fairly stable compared to the past year.

In accordance with the company's disclosures, CannBioRx Life Sciences has a Working Capital of (1.42 Million). This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The working capital for all United States stocks is notably higher than that of the company.

CannBioRx Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CannBioRx Life's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CannBioRx Life could also be used in its relative valuation, which is a method of valuing CannBioRx Life by comparing valuation metrics of similar companies.

CannBioRx Life is currently under evaluation in working capital category among its peers.

CannBioRx Fundamentals

	Return On Equity	-3.99
	Return On Asset	-0.63
	Number Of Shares Shorted	10.74 K
	EBITDA	(22.13 M)
	Net Income	(19.94 M)
	Total Debt	1.05 M
	Book Value Per Share	(0.24) X
	Cash Flow From Operations	(10.92 M)
	Beta	0.25
	Market Capitalization	250.78 M
	Total Asset	5.26 M
	Retained Earnings	(127.34 M)
	Working Capital	(1.42 M)
	Net Asset	5.26 M

About CannBioRx Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CannBioRx Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannBioRx Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannBioRx Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC